Keck School of Medicine of USC
A

What's New in the Medical Management of Diabetes? A 2024 Guidelines Update

By Keck School of Medicine of USC FEATURING Alyssa Lampe Dominguez
By Keck School of Medicine of USC FEATURING Alyssa Lampe Dominguez
18 views
October 21, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

13:03
Novartis Cardiology

Expert Insights on Adding a Non-Statin Lipid-Lowering Therapy in a R…

Feat. M. Koren

Featured Video

02:17
Novartis Cardiology

Understanding Acquisition and Billing for a Non-Statin Lipid-Lowerin…

Feat. B. Buell

Related Content

AUTOPLAY
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
12:04
Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason
34:49
Scripps Health

Medications for Weight Loss: The New Satiety Hormones

Feat. K. Fujioka
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
15:53
Heart in Diabetes (HiD)

Medical Treatment of Hypercortisolism With Relacorilant: Final Resul…

Feat. R. Pivonello
08:35
Susan Brian

Labs to Check on Semaglutide or Tirzepatide

20:15
Omnipod®

Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D

Feat. F. Pasquel
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

40:48
Michigan Medicine

Incretin-based Therapies in the Management of Obesity and its Comorb…

Feat. A. Rothberg
26:49
Diana Isaacs

Tirzepatide Updates

07:41
Susan Brian

Weightloss in Menopause